Evidence map›Paper›PMID 15059283›Full record

ArticleBMC biology2004

Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.

Jörg M Harms, Frank Schlünzen, Paola Fucini, Heike Bartels, Ada Yonath

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 170 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ribosome-targeting antibiotics and resistanceRSC medicinal chemistry · 2023
    Review
  9. Review
  10. RNA-Binding Macrocyclic Peptides.Frontiers in molecular biosciences · 2022
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jörg M HarmsMax-Planck Research Unit for Ribosomal Structure, 22603 Hamburg, Germany. harms@riboworld.com <harms@riboworld.com>
Frank Schlünzen
Paola Fucini
Heike Bartels
Ada Yonath
Max Planck Unit for Structural Molecular Biology · DEMax Planck Institute for Molecular Genetics · DE

Funding

CRYSTALLOGRAPHIC STUDIES ON RIBOSOMAL PARTICLESR01GM034360 · NIGMS · WEIZMANN INSTITUTE OF SCIENCE · PI YONATH, ADA E · 1985 to 2010
$2.2M
NIGMS NIH HHS GM34360NIGMS NIH HHS R01 GM034360
6 · The paper itself

Abstract

backgroundThe bacterial ribosome is a primary target of several classes of antibiotics. Investigation of the structure of the ribosomal subunits in complex with different antibiotics can reveal the mode of inhibition of ribosomal protein synthesis. Analysis of the interactions between antibiotics and the ribosome permits investigation of the specific effect of modifications leading to antimicrobial resistances. Streptogramins are unique among the ribosome-targeting antibiotics because they consist of two components, streptogramins A and B, which act synergistically. Each compound alone exhibits a weak bacteriostatic activity, whereas the combination can act bactericidal. The streptogramins A display a prolonged activity that even persists after removal of the drug. However, the mode of activity of the streptogramins has not yet been fully elucidated, despite a plethora of biochemical and structural data.

resultsThe investigation of the crystal structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with the clinically relevant streptogramins quinupristin and dalfopristin reveals their unique inhibitory mechanism. Quinupristin, a streptogramin B compound, binds in the ribosomal exit tunnel in a similar manner and position as the macrolides, suggesting a similar inhibitory mechanism, namely blockage of the ribosomal tunnel. Dalfopristin, the corresponding streptogramin A compound, binds close to quinupristin directly within the peptidyl transferase centre affecting both A- and P-site occupation by tRNA molecules.

conclusionsThe crystal structure indicates that the synergistic effect derives from direct interaction between both compounds and shared contacts with a single nucleotide, A2062. Upon binding of the streptogramins, the peptidyl transferase centre undergoes a significant conformational transition, which leads to a stable, non-productive orientation of the universally conserved U2585. Mutations of this rRNA base are known to yield dominant lethal phenotypes. It seems, therefore, plausible to conclude that the conformational change within the peptidyl transferase centre is mainly responsible for the bactericidal activity of the streptogramins and the post-antibiotic inhibition of protein synthesis.

Indexed as

Anti-Bacterial AgentsBinding SitesCrystallizationDeinococcusDrug SynergismPeptidyl TransferasesRibosomal ProteinsRibosomesRNA, Ribosomal, 23SVirginiamycinAnti-Bacterial AgentsdalfopristinPeptidyl TransferasesquinupristinRibosomal ProteinsRNA, Ribosomal, 23SVirginiamycin

Identifiers

PMID15059283
PMCPMC400760
OpenAlexW2139319648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.